The name iKnife may
sound like the name a certain technology company would give its
products if it ever branched into the kitchen cutlery business, but
you can rest assured that intelligent knife (iKnife) technology is
revolutionizing the way we excise cancer tissue.
What is iKnife technology?
Normal electrosurgical knives removes tissue using a sharp edge and a rapid heating element to vaporize the tissue that it directly contacts; this creates clean cuts that allow for the quick and easy excision of cancer tissues. The iKnife technology takes this action a step farther. When an electrosurgical knife vaporizes tissue, it creates a tissue fragment containing aerosol that is usually disposed of by vacuum extraction tools; instead of allowing this vapor to go to waste, an iKnife immediately collects and analyzes this aerosol vapor, and determines whether or not it includes cancerous tissue within seconds. This vastly improves the accuracy of surgical cutting.
How will iKnife technology aid in the collection of cancer tissue?
First and foremost, improving the speed of surgical cuts increases patient safety during excision procedures. Current excision procedures require the separate collection and rapid evaporative ionization mass spectrometry (REMS) testing of excised tissue to determine whether or not it is cancerous. The separate (REMS) process can take up to 30 minutes and the patient remains under anesthesia during this time; finding ways to reduce patient anesthesia time has always been a key element in improving patient safety during surgical procedures.
iKnife excision is also improving the precision of cancer excision procedures. This precision further improves the safety of the patient during an excision procedure by instantaneously confirming that the tissue being excised is indeed cancer tissue. In addition, a large percentage of cancer patients have to undergo multiple surgeries to remove cancer tissue that was missed during the initial excision procedure--this number is 20% for breast cancer lumpectomies--the increased precision of iKnife technology will greatly reduce the number of occurrences of multiple excision treatments AND cancer relapses. This precision also enhances the ability for scientists to collect cancer tissues in the largest possible volumes for biological research; this will be a huge boon for biological research involving especially rare cancer tissues such as most sarcomas and endocrine organ cancers.
In the world of biological science, where a single experiment can take months, or even years, efficiency is everything. By improving the accuracy and volume of cancer tissue excisions, iKnife technology is inherently improving the speed of the excision of cancer tissues.
Where can iKnife surgical technology be acquired?
The iKnife technology is still undergoing development to maximize the potential of iKnives in practical settings. Clinical testing thus far has yielded excellent results and researchers are working to maximize the cost effectiveness of the tool.
What is iKnife technology?
Normal electrosurgical knives removes tissue using a sharp edge and a rapid heating element to vaporize the tissue that it directly contacts; this creates clean cuts that allow for the quick and easy excision of cancer tissues. The iKnife technology takes this action a step farther. When an electrosurgical knife vaporizes tissue, it creates a tissue fragment containing aerosol that is usually disposed of by vacuum extraction tools; instead of allowing this vapor to go to waste, an iKnife immediately collects and analyzes this aerosol vapor, and determines whether or not it includes cancerous tissue within seconds. This vastly improves the accuracy of surgical cutting.
How will iKnife technology aid in the collection of cancer tissue?
First and foremost, improving the speed of surgical cuts increases patient safety during excision procedures. Current excision procedures require the separate collection and rapid evaporative ionization mass spectrometry (REMS) testing of excised tissue to determine whether or not it is cancerous. The separate (REMS) process can take up to 30 minutes and the patient remains under anesthesia during this time; finding ways to reduce patient anesthesia time has always been a key element in improving patient safety during surgical procedures.
iKnife excision is also improving the precision of cancer excision procedures. This precision further improves the safety of the patient during an excision procedure by instantaneously confirming that the tissue being excised is indeed cancer tissue. In addition, a large percentage of cancer patients have to undergo multiple surgeries to remove cancer tissue that was missed during the initial excision procedure--this number is 20% for breast cancer lumpectomies--the increased precision of iKnife technology will greatly reduce the number of occurrences of multiple excision treatments AND cancer relapses. This precision also enhances the ability for scientists to collect cancer tissues in the largest possible volumes for biological research; this will be a huge boon for biological research involving especially rare cancer tissues such as most sarcomas and endocrine organ cancers.
In the world of biological science, where a single experiment can take months, or even years, efficiency is everything. By improving the accuracy and volume of cancer tissue excisions, iKnife technology is inherently improving the speed of the excision of cancer tissues.
Where can iKnife surgical technology be acquired?
The iKnife technology is still undergoing development to maximize the potential of iKnives in practical settings. Clinical testing thus far has yielded excellent results and researchers are working to maximize the cost effectiveness of the tool.
No comments:
Post a Comment